LINDSEY MARTIN: Open Payments
NPI 1093348732 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 19 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $95 |
| Boston Scientific Corporation | 2 | $76 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $50 |
| Optinose US, Inc. | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Stryker Corporation | 1 | $18 |
| Greer Laboratories, Inc. | 1 | $16 |
Products named: DUPIXENT, NEFFY, General - Catheters, Xhance, Peripheral RotaLink Plus, HYQVIA, Rhapsido, CLARIFIX.
Industry payments across NJ — which companies pay providers there.
